References
- Jaffe I A. Rheumatoid arthritis with arteritis Report of a case treated with penicillamine. Ann Intern Med 1964; 61: 556–63
- Jaffe I A. Penicillamine treatment of rheumatoid arthritis with a single daily dose of 250 mg. Proc Roy Soc Med 1977; 70((suppl) 3)130
- Jaffe I A. The technique of penicillamine administration in rheumatoid arthritis. Arthritis Rheum 1975; 18: 513
- Kean W F., Anastassiades T P., Dwosh I L., Ford P M., Kelly W G., Dok C M. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly. J Am Ger Soc 1982; 30: 94–100
- Jaffe IA. D-penicillamine. Bull Rheum Dis 1978; 28: 948–52
- Hill H FH, Hill A GS, Day A T., Brown R M., Golding J R., Lyle W H. Maintenance dose of penicillamine in rheumatoid arthritis: a comparison between a standard and a response-related flexible regimen. Ann Rheum Dis 1979; 38: 429–33
- Stockman A, Richter D, Barraclough D, Murieden K D., Macdonald I, Kincaid-Smith P. Difficulties in the use of D-penicillamine in the treatment of rheumatoid arthritis. Aust NZ J Med 1979; 9: 495–503
- Day A T., Golding J R., Lee P N., Butterworth A D. Penicillamine in rheumatoid disease: A long term study. Br Med J 1974; is: 180–83
- Williams H J., Ward J R., Reading J C., et al. Low-dose D-penicillamine therapy in rheumatoid arthritis. Arthritis Rheum 1983; 26: 581–92
- Dixon A, St J, Davis J, Dormandy T L., et al. Synthetic D-penicillamine in rheumatoid arthritis. Ann Rheum Dis 1975; 34: 416–21
- Rhopes M W., Bennet G A., Cobb S, Jacox R, Jessar R A. Diagnostic criteria for rheumatoid arthritis: 1959 revision. Bull Rheum Dis 1958; 9: 175–76
- Stein H B., Patterson A C., Offer R C., Atkins C J., Teufel A, Robinson H S. Adverse effects of D-penicillamine in rheumatoid arthritis. Ann Int Med 1980; 92: 24–9
- Halverson P. Toxicity of penicillamine. JAMA 1978; 240: 1870–71
- Multicentre Trial Group. Controlled trial of D-penicillamine in severe rheumatoid arthritis. Lancet 1973; 275–80
- Kean W F., Dwosh I L., Anastassiades T P., Ford P M., Kelly H G. The toxicity pattern of D-penicillamine therapy. Arthritis Rheum 1980; 23: 158–64
- Nissilä M, Nuptio P, von Essen R, Mäkisara P. Low-dose penicillamine treatment of RA. Scand J Rheumatol 1982; 11: 161–64
- Ward J R. Low dose D-penicillamine therapy in rheumatoid arthritis: a 36-week controlled multicentre trial comparing 125 mg per day. 500 mg per day and placebo. A preliminary report of the Cooperating Clinics for the Systematic Study of Rheumatic Diseases. Modulation of autoimmunity and disease, R N. Maini, H Berry. The penicillamine experience, Praeger 1981; 178–88